Protein tyrosine kinase activities of the epidermal growth factor receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics by Nair, Nandini et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Open Access Articles Open Access Publications by UMMS Authors 
1992-05-01 
Protein tyrosine kinase activities of the epidermal growth factor 
receptor and ErbB proteins: correlation of oncogenic activation 
with altered kinetics 
Nandini Nair 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/oapubs 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Repository Citation 
Nair N, Davis RJ, Robinson HL. (1992). Protein tyrosine kinase activities of the epidermal growth factor 
receptor and ErbB proteins: correlation of oncogenic activation with altered kinetics. Open Access 
Articles. Retrieved from https://escholarship.umassmed.edu/oapubs/1463 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Open Access Articles 
by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
MOLECULAR AND CELLULAR BIOLOGY, May 1992, p. 2010-2016
0270-7306/92/052010-07$02.00/0
Copyright © 1992, American Society for Microbiology
Protein Tyrosine Kinase Activities of the Epidermal Growth
Factor Receptor and ErbB Proteins: Correlation of
Oncogenic Activation with Altered Kinetics
N. NAIR,' R. J. DAVIS,' AND H. L. ROBINSON`*
Department of Pathology' and Howard Hughes Medical Institute, University of
Massachusetts Medical Center, Worcester, Massachusetts 01655
Received 14 November 1991/Accepted 5 February 1992
We have compared the protein tyrosine kinase activities of the chicken epidermal growth factor receptor
(chEGFR) and three ErbB proteins to learn whether cancer-activating mutations affect the kinetics of kinase
activity. In immune complex assays performed in the presence of 15 mM Mn2', ErbB proteins and the
chEGFR exhibited highly reproducible tyrosine kinase activity. Under these conditions, the ErbB and chEGFR
proteins had similar apparent Km [Km(app)] values for ATP. The ErbB proteins appeared to be activated, as
they had at least 3-fold-higher relative Vmax(app) for autophosphorylation and -2-fold higher relative
Vmax(app) for the phosphorylation of the exogenous substrate TK6 (a bacterially expressed fusion protein
containing the C-terminal domain ofthe human EGFR). The ErbB kinases had both higherKm(app) and higher
Vmax(app) for the phosphorylation of the exogenous substrate TK6 than did the chEGFR. The ratios of the
Vmax(app) to the Km(app) for TK6 phosphorylation suggested that the ErbB proteins had lower catalytic
efficiencies for the exogenous substrate than did the chEGFR. The three tested ErbB proteins had cytoplasmic
domain mutations that conferred distinctive disease potentials. These mutations did not affect the kinetics for
the phosphorylation of the exogenous substrate TK6. Two of the ErbB proteins contained all of the sites used
for autophosphorylation. In these, a mutation that broadened oncogenic potential to endothelial cells caused an
additional increase in Vmax(app) for autophosphorylation. Thus, mutations that change the EGFR into an ErbB
oncogene cause multiple changes in the kinetics of protein tyrosine kinase activity.
The v-erbB oncogenes of avian erythroblastosis viruses
(AEV) arise by recombination of an avian leukosis virus with
host sequences encoding the transmembrane and cytoplas-
mic domains of the chicken epidermal growth factor receptor
(chEGFR). The EGFR consists of four functional domains:
an extracellular epidermal growth factor (EGF)-binding N
terminus, a short transmembrane domain, a tyrosine kinase
domain, and a C terminal domain containing the major sites
of EGF-stimulated autophosphorylation (for a review, see
reference 28). Thirty to forty independent isolates of AEV
have been identified (2, 5, 11, 18, 22). The EGF-binding
domain is truncated in all of these isolates. Many also
contain point mutations, truncations, or internal deletions in
the cytoplasmic domain of the receptor. These mutations
determine differences in the potential to induce erythroblas-
tosis, angiosarcoma, hemangioma, or fibrosarcoma (7, 21,
22, 24, 27).
The tyrosine kinase activity of the EGFR is required for its
mitogenic activity (28). Analysis of the transformation po-
tential of a series of linker insertion mutations in ErbB
suggests that kinase activity is required for transformation
(20). As ErbB lacks the EGF-binding domain, its kinase
activity has been hypothesized to cause transformation by
virtue of its activity being ligand independent. This study
was undertaken to determine whether truncation of the
ligand-binding domain affected the kinetics as well as the
ligand dependence of kinase activity.
Prior studies with ErbB proteins have demonstrated ty-
rosine kinase activity for autophosphorylation and the phos-
phorylation of synthetic peptides (3, 8, 9, 10, 15). Prior
* Corresponding author.
studies have also tested whether cytoplasmic domain muta-
tions that broaden the transforming potential of ErbB affect
in vivo levels of autophosphorylation. These tests suggested
that about one-half of activating mutations (three of six
tested) would be associated with increased levels of in vivo
autophosphorylation (24, 25).
Constructed proteins have also been used to analyze the
effects of different domains of the EGFR on tyrosine kinase
activity. Assays using the human EGFR and 66- and 42-kDa
forms of the cytoplasmic domain have revealed many differ-
ences in kinetic activities (14, 29). Millimolar levels of the
divalent cation Mn2+ activate the activity of the holorecep-
tor and support the activity of the fragments. In the presence
of similar levels of Mg2+, the activity of the holoreceptor is
EGF dependent and the fragments are largely inactive. The
relative activities of the holoreceptor and its fragments also
depend on salt conditions (14, 29). In the presence of Mn2+
and low salt, the 42-kDa fragment and holoreceptor have
similar activities, whereas the 66-kDa fragment has a lower
specific activity. In the presence of Mn2+ and high salt (1 M
NH4SO4), the receptor becomes EGF dependent, the 42-
kDa fragment is inactive, and the 66-kDa form is more active
than the EGF-stimulated holoreceptor.
To test for a potential role of the kinetics of kinase activity
in oncogenic potential, the kinase activities of three ErbB
proteins were compared with that of the chEGFR. Each of
the ErbB proteins represented approximately 80- to 85-kDa
glycoproteins that contain the transmembrane as well as
cytoplasmic domains of the chEGFR. The first, AEV-5005
ErbB, represented a nonmutated, C-terminal complete ErbB
that causes only erythroblastosis (7, 27). The second, AAV-
5005 ErbB, served as an example of an ErbB that transforms
erythroid as well as endothelial cells (7, 27). The ability of
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FIG. 1. Schematic representations of the chEG
proteins. Numbers designate amino acid positions i:
(17). Tyrosine residues that are homologs of the site
phorylation in the human EGFR and the lysine that
of the site for ATP binding are designated Y and K, re
activating mutation of valine 706 to isoleucine in the
of AEV-H ErbB is designated I (24). A. sequence:
leukosis virus Gag protein; sequence against w:
antibody is directed; TM, transmembrane domain.
this ErbB to transform endothelial cells is dete
in-frame deletion in its C-terminal domain (27
AEV-H ErbB, was used to represent an erythrc
as fibroblast-transforming ErbB protein (30).
ErbB has an activating point mutation in the
region of its kinase domain as well as a C-termir
(21, 24). Our results indicate that each of the E
differed from the chEGFR in the kinetics of
kinase activities. We suggest that these kineti
contribute to the transforming potential of Erb
MATERIALS AND METHODS
EGFR and ErbB glycoproteins. Figure 1 prese
ics of the chEGFR and ErbB proteins used in tI
chEGFR was obtained from a murine EC
chEGFR-expressing clone of NIH 3T3 cells (1
passage chicken embryo fibroblasts (CEF). 1
ferred to as chEGFR (NIH 3T3) and chE!
respectively. The ErbBs of AEV-5005 and AA
expressed by plasmid srE- and srE/A-transfecte
of a transformed quail cell line, QT6 (19). srE
ErbB gene of AEV-5005. srE/A represents a rei
srE containing the internal deletion of the Er
5005 (27). The ErbB of AEV-H was expressed
by a spreading infection initiated by cotransfe
lecular clones of AEV-H (pAE 7.7) (30) and a
pRAV-IOR (23). Nontransfected QT6 cells we
source of the quail EGFR (quEGFR).
Antisera. Immunoprecipitations were done X
polyclonal rabbit serum raised against the N tern
(Fig. 1) by using a bacterially expressed TrpE fi
A 463-bp region at the 5' end of the v-erbl
(ApaI-to-BamHI fragment from pAE7.7) was cl
pATH1O vector (4) and expressed in Eschenchit
a 54-kDa protein. Bands containing the fusion
cut from sodium dodecyl sulfate (SDS)-polyaci
and homogenized in the presence of Freuni
adjuvant. Homogenates containing -300 p.g (
protein (-1 ml) were injected into the thigh mu
Zealand White rabbits. Four weeks later,
boosted by intramuscular inoculation with -1
fusion protein in the presence of Freund incompl
utophosphorylation High-titered sera were obtained 2 weeks following the first
Y Y Y boost as well as 2 weeks following each of three subsequent
boosts. A monoclonal antibody, 20.3.6, raised by M. Hayman
(State University of New York, Stony Brook) against the
Y Y " " kinase region of the ErbB gene of AEV-R was used for
protein blot analyses. A mouse monoclonal antibody, PY20
y y (ICN, Costa Mesa, Calif.), was used to detect phosphoty-
rosine.
In vitro kinase assay. A total of 10 x 106 to 20 x 106 cells
Y y y y | expressing the chEGFR or ErbB were solubilized per ml ofice-cold lysis buffer (50 mM N-2-hydroxyethylpiperazine-
N'-2-ethanesulfonic acid [HEPES; pH 7.4], 500 mM NaCl, 5
mM EGTA, 1% Triton X-100, 10% glycerol, 50 mM NaF,
;FR and ErbB 200 ,uM sodium orthovanadate, 10 p.g of leupeptin per ml).
n the chEGFR Lysates were placed on ice and clarified by centrifugation at
Ss of autophos- 4°C for 20 min at 16,000 rpm in the SS34 rotor in a Sorvallis the homolog RC5B centrifuge. For each point of a kinase assay, 1 ml of
-spectively. An
kinase domain supernatant was immunoprecipitated with 25 p.l (packed
from the avian volume) of protein A-Sepharose CL4B beads (Sigma, St.
hich the NN-1 Louis, Mo.) that had been preincubated at room temperature
for 40 min with 7 p,l of NN-1 and 63 ,ul of lysis buffer and then
washed four times with lysis buffer. Immunoprecipitations
were done on a rocker in a cold room (5 to 7°C) for 90 min.
rmined by an Beads were then washed two times with lysis buffer and two
7). The third, times with HNTG (50 mM HEPES [pH 7.4], 150 mM NaCl,
)blast- as well 0.1% Triton, 10% glycerol, 50 mM NaF, 200 p.M sodium
The AEV-H orthovanadate). Kinase reactions were run in 50 p,l of
ATP-binding reaction buffer (HNTG supplemented with 15 mM MnCl2
ial truncation and 1 mM dithiothreitol) containing from 0.25 to 125 p.M
_rbB proteins ATP (Pharmacia, Piscataway, N.J.) and from 0 to 40 p.M
f its tyrosine TK6 (an exogenous substrate; see below). ATP was adjusted
ic differences to a specific activity (s.a.) of 5 to 15 p,Ci/nmol with
)B proteins. [y-32P]ATP (Amersham, Arlington Heights, Ill.). Reaction
mixtures were incubated at 25°C for 70 s for studies on
autophosphorylation and at 25°C for 10 min for studies on
the phosphorylation of exogenous substrates (see Results for
:nts schemat- linearity of reactions). Reactions were stopped by the addi-
he study. The tion of an equal volume of 2x SDS-sample buffer (16). The
JFR-negative samples were boiled for 2 min prior to SDS-polyacrylamide
L7) and early- gel electrophoresis (SDS-PAGE) analysis. Incorporated 32p
rhese are re- was visualized by autoradiography and quantitated by Beta-
GFR (CEF), scope analysis (Betascope 603; Betagen, Waltham, Mass.) of
iV-5005 were dried gels. Kinetic parameters were obtained by using the
-d clones (27) Michaelis-Menten analyses in the computer program ENZ-
encodes the FITTER (Elsevier-Biosoft).
combinant of Exogenous substrate. TK6, a fusion of the glutathione
*bB of AAV- S-transferase protein with the C-terminal region of the
in QT6 cells human EGFR, was used as an exogenous substrate (14).
-ction of mo- This protein was expressed by pGEX-TK6-transformed
helper virus, BL21 bacterial cells and purified by using the reported
-re used as a protocol with the modification of the use of a Sephadex G-25
PD 10 gel filtration column (Pharmacia) to remove residual
vith NN-1, a glutathione from samples. The purity and integrity of TK6
ninus of ErbB were verified by SDS-PAGE, and the concentration was
asion protein. determined using the Bradford assay (Bio-Rad, Richmond,
B of AEV-H Calif.) with a bovine serum albumin (BSA) standard.
Ioned into the Western immunoblots. Proteins were electroblotted on
a coli DH1 as nitrocellulose paper (26), using 0.3% Trizma base-1.5%
protein were glycine-0.037% SDS-20% methanol as the transfer buffer.
rylamide gels The rat monoclonal antibody 20.3.6 (see above) was used to
d's complete detect EGFR and ErbB proteins, rabbit anti-rat immuno-
of the fusion globulin G (Organon Teknika, Durham, N.C.) was used to
scles of New detect the bound monoclonal antibody, and 2"I-protein A
rabbits were (-10 p.Ci/100 ml; Amersham, Arlington Heights, Ill.) was
.00 p.g of the used to detect the bound rabbit immunoglobulin. BSA (3%)
lete adjuvant. was used to reduce nonspecific binding. Bound 125I was
EGF binding TM kinase a
chEGFR
AEV-5005 ErbB
AEV-H ErbB
AAV-5005 ErbB
-
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visualized on autoradiograms, and the relative amounts of
EGFR and ErbB proteins were quantitated by computer-
assisted image analysis, using the software program IM 100
Densitometry (Microscience, Seattle, Wash.).
RESUiLTS
Choice of reaction conditions and exogenous substrate. To
carry out comparative kinetic analyses on ErbB and
chEGFR proteins, pilot reactions were performed to identify
conditions that would give reproducible activity for exoge-
nous substrates. These pilot tests revealed good activity for
the exogenous substrate TK6 but very poor activity for
enolase and a Src substrate peptide (RRLIEDAEYAARG).
TK6 was therefore used in further studies. TK6 contains the
autophosphorylation sites of the human EGFR and repre-
sents a homolog of the sites that undergo autophosphoryla-
tion in EGFR and ErbB proteins (14). In initial experiments
using millimolar levels of Mg2", no reproducible activity for
TK6 was observed. In contrast, experiments using 15 mM
Mn2" demonstrated reproducible tyrosine phosphorylation
of TK6. Other ligand-domain-truncated forms of the EGFR
have also shown a strong preference for Mn2+ over Mg2`
(13, 29). On the basis of these pilot tests, detailed studies
were conducted under physiological salt conditions (150 mM
NaCl), using TK6 as the exogenous substrate and 15 mM
Mn2+ as the divalent cation.
Autophosphorylation activity of the chEGFR and ErbB
proteins. To establish the time course and specificity of
autophosphorylation, immune complexes were prepared and
in vitro kinase assays were examined for autophosphoryla-
tion activity with time of incubation at 25°C (Fig. 2). Auto-
phosphorylation of the chEGFR (Fig. 2A) was linear for at
least 4 min, whereas autophosphorylation of the AEV-5005
ErbB was linear for approximately 2 min (Fig. 2B). Evidence
that the phosphorylation activity was a tyrosine protein
kinase was obtained by incubating protein blots of kinase
reactions with the antiphosphotyrosine antibody PY20.
These blots revealed a more than 50-fold increase of phos-
photyrosine in chEGFR and ErbB proteins during kinase
reactions (data not shown). 32P-labeled reaction products
were also analyzed for phosphoamino acid content. These
analyses revealed phosphotyrosine and not phosphoserine
or phosphothreonine (data not shown). On the basis of these
results, further studies on autophosphorylation were carried
out for 70 s at 25°C, and all incorporated 32p counts were
assumed to represent phosphorylation on tyrosine.
The apparent concentration of ATP required for half-
maximal rates of autophosphorylation [Km(app)] and the
relative Vmax(app) of the chEGFR and ErbB kinases (AEV-
5005 and AAV-5005) were next determined (Table 1). The
AEV-H protein was not included in this study because of its
C-terminal truncation that includes one of the major sites of
autophosphorylation (Fig. 1). ATP concentrations of 1 to 50
,uM (s.a., 6.4 p,Ci/nmol) were used in reactions. Kinase
assays on the chEGFR were carried out in the absence of
ligand. The chEGFR from NIH 3T3 cells and from CEF and
the two tested ErbB proteins had similar KJ(app) values.
These values were in good agreement with previously pub-
lished values for immune complex kinase assays for the
EGFR and ErbB kinases (12, 24). In contrast to the similar-
ity of the ATP requirements, the relative Vm. for autophos-
phorylation were distinctly higher for the ErbB than the
chEGFR kinases: the ErbB of AEV-5005 had at least a
threefold-higher and the ErbB of AAV-5005 had at least a
sevenfold-higher autophosphorylation activity than did the
A chEGFR
05 2 4
-gpl70
B AEV 5005 EBoFB
f,, 5 ? 4
..a _
5p R5b
2c -,
2 4 4
Miru'es eIn s
FIG. 2. Time course of autophosphorylation. Autoradiograms as
well as graphic representations are presented for NN-1 immunopre-
cipitates of the chEGFR (NIH 3T3) (A) and the ErbB of AEV-5005
(B). Designations above the lanes indicate the times of reaction in
minutes. Designations on the sides indicate the positions of the
chEGFR (gpl70) and ErbB (gp85-88). For details on conditions, see
Materials and Methods.
chEGFR. This increased maximum velocity was consistent
with the time course of autophosphorylation reactions that
had revealed autophosphorylation of ErbB being linear over
a more limited time span than autophosphorylation of the
chEGFR (Fig. 2).
Phosphorylation activity of the chEGFR and ErbB proteins
for the exogenous substrate TK6. As the first step to eluci-
dating phosphorylation activity for an exogenous substrate,
immunoprecipitates of the chEGFR and the AEV-5005 ErbB
were prepared and the linearity with time of kinase activity
for TK6 was determined (Fig. 3). These assays revealed a
linear incorporation of 32p on the 54-kDa TK6 protein for at
TABLE 1. Autophosphorylation activities of the chEGFR
and ErbB proteinsa
Protein Km(app) for Relative VmaxProtein ATP (,M) (fmol/min)
chEGFR (NIH 3T3) 6.4 ± 2.5 21.5 + 2.5
chEGFR (CEF) 6.0 ± 1 15.4 + 1.0
AEV-5005 ErbB 3.3 ± 0.4 61.5 ± 1.2
AAV-5005 ErbB 6.2 ± 1 153.9 ± 6.2
a Immune complex kinase assays were carried out with the indicated
chEGFR or ErbB proteins in the presence of 1 to 125 ,M ATP (s.a., 6.4
,uCi/nmol). Relative Vm,,, values were calculated by using data obtained on
protein blots to normalize the amounts of the ErbB or EGFR proteins to the
amount of the EGFR in the chEGFR (NIH 3T3) samples. These normaliza-
tions reduced the V ,,,(app) values obtained for the ErbB proteins by two- to
fourfold.
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A chEGFR B AEV-5005 ErbB
2 4 8 16 5 8 16
-gp170
I gp85-88
54
_m _
-10 ~20-
E 10Xl
5 1
10 20 8 16
Minutes Minutes
FIG. 3. Time course of TK6 phosphorylation. Autoradiograms
as well as graphic representations are presented for NN-1 immuno-
precipitates of the chEGFR (NIH 3T3) (A) and the ErbB of
AEV-5005 (B). Designations above the lanes indicate the times of
reaction in minutes. Designations on the sides indicate the positions
of the chEGFR (gpl70), ErbB (gp85-88) and TK6 (54 kDa [54]). For
details on conditions, see Materials and Methods; 7.5 ,uM TK6 was
used in the reactions.
least 16 to 20 min. On the basis of these experiments, further
assays on the phosphorylation activity of the tyrosine ki-
nases for the TK6 substrate were done with a 10-min
incubation at 25°C.
The Km(app) for ATP during the phosphorylation of an
exogenous substrate was determined by using 7.5 p,M TK6.
In experiments in which the concentration of ATP was
varied from 1 to 60 p,M, the Km(app) for ATP was 20 to 34
,uM (Table 2). To determine the relative Vm((app) of these
reactions, aliquots of the immune complexes were saved and
analyzed on protein blots for the relative amounts of
chEGFR and ErbB proteins. Normalization of the Vm~,(app)
TABLE 2. Effects of ATP concentration on phosphorylation of
the TK6 substrate by chEGFR and ErbB proteins'
Protein Km(app) for Relative Vma,,(app)ATP (puM) (fmol/min)
chEGFR (NIH 3T3) 33.8 ± 4.7 3.4 ± 0.3
AEV-5005 ErbB 26.1 ± 3.9 6.8 ± 0.3
AAV-5005 ErbB 20.1 ± 2.5 6.8 ± 0.3
AEV-H ErbB 30.1 ± 3.1 5.1 ± 0.2
a Immune complex kinase assays were carried out with the chEGFR (NIH
3T3) or ErbB proteins in the presence of 7.5 ,uM TK6 and 1 to 50 F.M ATP
(s.a., 13.3 pCi/nmol). The Vmax(app) values for the ErbB proteins were
divided by values ranging from 2 to 3 to obtain values relative to that of the
chEGFR (NIH 3T3).
TABLE 3. Effects of substrate TK6 concentration on
phosphorylation by chEGFR (NIH 3T3) and ErbB proteinsa
Protein K6(app) for Relative Vmn,,(app)TK6 (pM) (fmol/min)
chEGFR (NIH 3T3) 0.5 ± 0.25 0.9 + 0.07
AEV-5005 ErbB 56 ± 19 25 ± 5
AAV-5005 ErbB 20 5 27 2
AEV-H ErbB 48 18 30 7
a Immune complex kinase assays were carried out with the indicated
chEGFR or ErbB proteins in the presence of TK6 (1.6 to 26 pM) and 50 pM
ATP (s.a., 10 pCi/nmol). The VmX,(app) values for the ErbB proteins were
divided by values ranging from 2 to 3 to obtain values relative to that of the
chEGFR (NIH 3T3).
for the relative levels of enzyme proteins revealed that the
relative Vmax(app) values for the three tested ErbB proteins
were about two times higher than that for the chEGFR (NIH
3T3) (Table 2).
The Km(app) for TK6 as well as the relative Vma,a(app) for
TK6 were next determined (Table 3). For these experiments,
immune complex kinase assays were carried out in the
presence of 50 ,uM ATP and concentrations of TK6 ranging
from 1.6 to 26,UM. The relative amounts of EGFR and ErbB
proteins in reaction mixes were quantitated by protein blot
analyses. In contrast to the studies on ATP requirement, in
which autoradiograms of SDS-PAGE-fractionated kinase
reactions revealed overall similar activities for each of the
kinases, the autoradiograms of the reactions testing TK6
requirements revealed easily visualized differences between
the tyrosine kinase activities of the chEGFR and ErbB
proteins. Figure 4A shows an example of these data for the
chEGFR and AEV-5005 ErbB proteins. Whereas the activity
of the chEGFR was not obviously increasing at concentra-
tions of TK6 above 3.2,UM, the activity of the ErbB kinase
was still increasing at a concentration of 26 p.M. The
maximum velocity of the ErbB kinase was also substantially
greater than that of the chEGFR, with similar levels of
kinase proteins resulting in just detectable levels of TK6
phosphorylation by the chEGFR and near-overexposed lev-
els of phosphorylation of TK6 by ErbB (Fig. 4A and B).
The kinetic parameters for the experiment in Fig. 4 were
calculated by using a curve-fitting program for the Michaelis-
Menten equation. The Km(app) for TK6 for the chEGFR was
0.5 ,uM (Table 3). In contrast the Km(app) for TK6 for each
of the three tested ErbB proteins was >20 ,uM (Table 3).
Quantitative determination of relative Vm,:(app) also re-
vealed differences, with the ErbB proteins having relative
Vmj,,(app) values that were at least 25 times higher than that
of the chEGFR (NIH 3T3). Among the ErbB proteins, all
had similar ATP requirements and similar relative Vmn,(app)
values (Table 3).
Because of the large difference in Vmax(app) between the
chEGFR (NIH 3T3) and the quail cell-expressed ErbB
proteins, the Vm.(app) and Km(app) for TK6 of the chEGFR(CEF) were analyzed to determine whether the kinetic
properties of this naturally occurring receptor were similar
to those of the expressed chEGFR. Also, as TK6 phosphor-
ylation in the ErbB immune complexes could reflect the sum
of the activities of ErbB and coprecipitated quEGFR pro-
teins (note the presence of autophosphorylation of the
quEGFR in Fig. 4), the activity of the quEGFR for TK6 was
determined in parallel so that the level of TK6 phosphory-
lation in ErbB immune complexes could be corrected for the
activity of coprecipitated quEGFR protein. Visualization of
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B AEV-5005
chEGFR ErbB
25 50 25 50
gpl 70-
*gp8-88
FIG. 4. Tyrosine kinase activities for TK6 of the chEGFR (NIH
3T3) and AEV-5005 ErbB. (A) Autoradiogram demonstrating the
kinase activities of immunoprecipitated chEGFR and AEV-5005
ErbB proteins for different concentrations of TK6. Designations
above the lanes indicate the concentrations (micromolar) of TK6; 50
pLM ATP (s.a., 10 ,uCi/nmol) was used in the reactions. (B) Autora-
diogram of a Western blot quantitating the relative amounts of
chEGFR and ErbB in kinase reactions. The same amount of
immunoprecipitate used for each kinase reaction was boiled in 100
,Ll of Laemmli sample buffer. Designations above the lanes indicate
the amounts (microliters) of sample analyzed. Designations on sides
indicate the chEGFR (gpl70), ErbB (gp85-88), and TK6 (54 kDa
[54]). For experimental details, see Materials and Methods.
autoradiograms of this experiment again revealed the differ-
ence in Km for TK6 of the chEGFR and ErbB kinases (Fig.
5). However, comparison of the relative rates of autophos-
phorylation and TK6 phosphorylation indicated that the two
chEGFRs differed in their relative activities for autophos-
phorylation and TK6 phosphorylation (Fig. 4A and 5).
Whereas the chEGFR (CEF) had comparable activities for
TK6 and autophosphorylation, the chEGFR (NIH 3T3) had
much lower kinase activity for TK6 than for autophos-
phorylation. The autoradiograms also revealed much higher
levels of autophosphorylation of the quEGFR in the immune
complexes from the ErbB-expressing QT6 cells than in the
immune complexes from control QT6 cells (Fig. 5). Western
blot analysis of this experiment revealed that this difference
correlated with the relative amounts of the quEGFR protein
in assays.
Table 4 summarizes the kinetic values calculated from the
experiment in Fig. 5. The calculated kinetic values for ErbB
are presented both with and without corrections for the
estimated level of TK6 phosphorylation by the quEGFR.
The Km(app) for TK6 for the chEGFR (CEF) was very
similar to that previously obtained for the chEGFR (NIH
AEV-5005
chEGFR quEGFR ErbB
3.2 6.4 13 26 3.2 6.4 13 26 32 64 13 26
-NH
pK! 88
54 -
FIG. 5. Kinase activities of the chEGFR (CEF), quEGFR, and
AEV-5005 ErbB. The autoradiogram demonstrates the kinase activ-
ities of immune complexes for different concentrations of TK6.
Western analyses of aliquots of the immune complexes used in these
analyses revealed twofold more quEGFR in the ErbB-expressing
QT6 cells than in the control QT6 cells and twofold more ErbB
protein than chEGFR protein. For details, see the legend to Fig. 4
and Materials and Methods.
3T3) and was again found to be at least 25-fold lower than
that of the ErbB kinase (Tables 3 and 4). Interestingly, the
Vmax(app) of the chEGFR (CEF) was much more similar to
that of the ErbB kinase than was the Vm,(app) of the
chEGFR (NIH 3T3), being only about 2-fold rather than
25-fold lower than that of ErbB (Tables 3 and 4). This
twofold difference was maintained when the data for ErbB
were corrected for the amount of TK6 phosphorylation by
the quEGFR.
DISCUSSION
Multiple differences in the kinetics of the tyrosine kinase
activities of chEGFR and ErbB proteins. (i) Activation of
kinase activity. Our kinetic analyses suggest that truncation
of the ligand-binding domain of the chEGFR increases the
kinase activity of the ErbB region of the receptor. This was
TABLE 4. Effects of substrate TK6 concentration on
phosphorylation by chEGFR (CEF) and
AEV-5005 ErbB proteinsa
Protein Km(app) for Relative Vmax(app)TK6 (,M) (fmol/min)
chEGFR (CEF) 0.7 ± 0.24 1.8 + 0.07
AEV-5005 ErbB 27 ± 16 5.8 + 2.0
AEV-5005 ErbBb 18 + 2 3.0 + 0.02
a Immune complex kinase assays were carried out with the indicated
proteins in the presence of TK6 (3.2 to 26 pM) and 50 p.M ATP (s.a., 10
plCi/nmol). The Vmax(app) for ErbB was divided by 2 to obtain values relative
to that of the chEGFR.
b Data have been corrected for the activity of the quEGFR as well as
normalized for the relative amounts of chEGFR and ErbB proteins. The
correction for the quEGFR activity was done by (i) determining the activity of
the quEGFR for TK6, (ii) multiplying this value by 2 to normalize for the
relative levels of the quEGFR in the ErbB-expressing quail cells, and (iii)
subtracting the normalized value from the level of TK6 phosphorylation in the
ErbB samples. The correction for TK6 phosphoryaltion by the quEGFR
represented about 30% of the amount of TK6 phosphorylation in the uncor-
rected ErbB samples.
A
chEGFR
16 3.2 64 13 0
gpl 70 Os S" O
54 -
AEV-5005 ErbB
'A 9 r, A 1oQ n),r
gpl 7o-
] gp85-88
-54
MOL. CELL. BIOL.
AL A.A.06. E54V -,
.
".:"w
-f":
.Y.
 at UNIV O
F M
ASS M
ED SCH on August 15, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
TYROSINE KINASE ACTIVITIES OF EGF RECEPTOR AND ErbB PROTEINS 2015
evidenced by ErbB proteins having at least 3-fold-higher
relative Vm,x(app) for autophosphorylation (Table 1) and
-2-fold-higher relative Vmax(app) for the phosphorylation of
an exogenous substrate (TK6) (Table 2). These increases in
Vmax were not accompanied by changes in the apparent Km
for ATP for autophosphorylation (Table 1) or the phosphor-
ylation of an exogenous substrate (Table 2). Thus the ErbB
proteins appear to be activated forms of the EGFR for
autophosphorylation as well as the phosphorylation of an
exogenous substrate.
(ii) Lower catalytic efficiency for an exogenous substrate.
Truncation of the ligand-binding domain of the EGFR had
complex consequences for the activity of the ErbB region of
the receptor for the exogenous substrate TK6 (Tables 3 and
4). In EGF-induced activation of the receptor, the velocity of
kinase reactions for peptide substrates increases without
marked changes in peptide requirements (6). In contrast, the
tested ErbB proteins had both increased relative Vm.(app)
and increased Km(app) for the exogenous substrate TK6
(Tables 3 and 4). One estimate of the catalytic efficiency of
an enzyme can be calculated as Vmaj/Km. The ratios of the
Vmax(app) to the Km(app) for the naturally occurring CEF
and AEV-5005 ErbB (Table 4) would suggest that the
chEGFR kinase has a 10-fold-greater catalytic efficiency for
TK6 than does the ErbB kinase. However, ErbB proteins do
have the potential for having higher kinase activities for TK6
than does the chEGFR if sufficient levels of TK6 are present
(Tables 3 and 4; Fig. 4 and 5). Such high concentrations
would be likely to have physiological relevance only for
substrates that bind to the C-terminal domain of the receptor
(such as SH2-domain-containing proteins [1]). The local
apparent concentration of such substrates could be quite
high. Indeed, the increased autophosphorylation activity of
ErbB may be an example of the effect of a tethered substrate
(Table 1).
(iii) Cell type dependence of activity. Interestingly, the
relative Vmax(app) but not the Km(app) for TK6 was affected
by the cell type expressing the chEGFR (Fig. 4 and 5; Tables
3 and 4). This was demonstrated by the chEGFR (CEF)
having a Vmax(app) for TK6 that was much more similar to
that of ErbB than was that of the chEGFR (NIH 3T3). This
strong effect of the cell of origin on the Vmax(app) warrants
further investigation. This effect could reflect a modification
of the receptor in NIH 3T3 cells that reduced the velocity of
the receptor kinase for exogenous substrates.
Autophosphorylation activity and broadening of the disease
potential of ErbB. Three ErbB proteins with distinct disease
potentials were compared for kinase activities. No differ-
ences were found in the activities of these ErbB kinases for
the exogenous substrate TK6 (Table 3). In contrast, analyses
for autophosphorylation activity revealed a 2.5-fold increase
in the Vm.(app) for the AAV-5005 ErbB relative to that of
the AEV-5005 ErbB (Table 1). The AAV-5005 ErbB causes
erythroblastosis and angiosarcoma, whereas the AEV-5005
ErbB causes only erythroblastosis (27). The correlation of an
increase in autophosphorylation activity with a mutation that
broadens oncogenic potential (Fig. 1) is consistent with in
vivo studies showing increased levels of phosphotyrosine on
ErbB proteins with certain activating mutations (24, 25). One
role for autophosphorylation of ErbB in the broadening of
transformation potential could be increased binding of sig-
nalling molecules with SH2 domains to the phosphorylated
forms of ErbB (1, 28).
Conditions used for kinetic analyses. The conclusions
drawn from our studies apply to our specific set of experi-
mental conditions. These conditions impose certain limits on
the interpretation of the results. (i) Assays were performed
with immune complexes. The NN-1 antiserum used for
immune complex kinase assays was raised against an ex-
pressed protein that extended into the kinase domain (Fig.
1). This antiserum could interfere with kinase activity and
affect the determined kinetic parameters. (ii) All ErbB as-
says were carried out in the presence of the quEGFR, with
ovlly the data in Table 4 being corrected for the apparent
activity of the quEGFR for the exogenous substrate. (iii) A
nonphysiological level of a divalent cation (15 mM Mn2+)
was used in reaction mixtures. This divalent cation activates
the kinase activity of the EGFR as well as the kinase activity
of fragments of the EGFR (13, 29). (iv) None of the assays
for EGFR kinase activity included ligand. (v) The affinity of
the monoclonal antibody used to evaluate relative levels of
chicken and quail proteins could have affected the accuracy
of the estimated values for Vma,(app). (vi) Our assays
included analyses of the kinetics for only one exogenous
substrate, TK6. Thus, our results apply for this substrate
and cannot be generalized to other substrates without deter-
mining the kinetics of reactions for these substrates.
Despite these caveats, this study is the first to compare the
kinetics of the activity of the chEGFR and ErbB kinases.
The results indicate that under a given set of conditions, the
ErbB kinase differs from the chEGFR kinase in its Vm.[(app)
for autophosphorylation, its relative Vm,(app) for an exog-
enous substrate, and its Km(app) for an exogenous substrate.
We suggest that these marked alterations in the kinetics of
kinase activity will contribute to the transforming potential
of the ErbB oncogene.
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